BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32023511)

  • 21. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
    Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO
    Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
    Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
    Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.
    Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR
    Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential delivery of synergistic drugs by silica nanocarriers for enhanced tumour treatment.
    Birault A; Giret S; Théron C; Gallud A; Da Silva A; Durand D; Nguyen C; Bettache N; Gary-Bobo M; Bartlett JR; Wong Chi Man M; Carcel C
    J Mater Chem B; 2020 Feb; 8(7):1472-1480. PubMed ID: 31995094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advances in Mesoporous Silica Nanoparticles for Targeted Drug Delivery Applications.
    Abu-Dief AM; Alsehli M; Al-Enizi A; Nafady A
    Curr Drug Deliv; 2022; 19(4):436-450. PubMed ID: 34238185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles.
    Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM
    J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency.
    Li J; Zhang W; Gao Y; Tong H; Chen Z; Shi J; Santos HA; Xia B
    J Mater Chem B; 2020 Jan; 8(3):546-557. PubMed ID: 31854435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
    Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
    Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesoporous silica nanoparticles as a breast-cancer targeting ultrasound contrast agent.
    Milgroom A; Intrator M; Madhavan K; Mazzaro L; Shandas R; Liu B; Park D
    Colloids Surf B Biointerfaces; 2014 Apr; 116():652-7. PubMed ID: 24269054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate-Lactoferrin Targeted Exemestane Cubosomes for Synergistic Breast Cancer Therapy.
    Mokhtar S; Khattab SN; Elkhodairy KA; Teleb M; Bekhit AA; Elzoghby AO; Sallam MA
    Front Chem; 2022; 10():847573. PubMed ID: 35392419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
    Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer.
    Sabra SA; Elzoghby AO; Sheweita SA; Haroun M; Helmy MW; Eldemellawy MA; Xia Y; Goodale D; Allan AL; Rohani S
    Eur J Pharm Biopharm; 2018 Jul; 128():156-169. PubMed ID: 29689288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.
    Romaní-Cubells E; Martínez-Erro S; Morales V; Chocarro-Calvo A; García-Martínez JM; Sanz R; García-Jiménez C; García-Muñoz RA
    J Nanobiotechnology; 2024 May; 22(1):249. PubMed ID: 38745193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
    Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
    ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.